South Africa will suspend the start of its Covid-19 vaccinations with the AstraZeneca jab after a study showed the drug failed to prevent mild and moderate cases of the virus variant that has appeared in the country. Africa’s hardest-hit nation was due to start its campaign in the coming days with a million doses of the vaccine developed by AstraZeneca and Oxford. The suspension marks an important setback for the country, but officials said vaccine deliveries from other producers would soon be available and allow the campaign to move forward. ‘It’s a temporary issue that we have to hold on AstraZeneca until we figure out these issues,’ Health Minister Zweli Mkhize told reporters during a virtual press conference. The special infection unit in the city of Tshwane, South Africa pushes a man showing symptoms of Covid-19 inside an ambulance The University of Witwatersrand, Johannesburg, which conducted the trial, said in a statement on Sunday that the AstraZeneca vaccine ‘provides minimal protection against mild-moderate Covid-19 infection’ from the South African variant. But in a full paper due to be published on Monday, AstraZeneca said that none of the 2,000 participants developed serious symptoms. That could mean it will still have an… Read full this story
- The global internet is disintegrating. What comes next?
- The medical student who died of measles
- How the malaria vaccine could change world health
- Malaria is fighting back against efforts to eliminate it
- The criminals put behind bars in Greater Manchester last month
- Summer lovin': Danger of getting an STI during festival season
South Africa suspends rollout of Oxford/AstraZeneca Covid jab after research showed it failed to prevent mild cases of mutant virus have 253 words, post on www.dailymail.co.uk at February 7, 2021. This is cached page on Europe Breaking News. If you want remove this page, please contact us.